BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28953116)

  • 21. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
    Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
    J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion triage in Korean women: Revisiting the 2012 American Society of Colposcopy and Cervical Pathology screening guidelines.
    Hyun JY; Min KJ; Yang SY; Lee JK; Hong JH
    Obstet Gynecol Sci; 2017 Jul; 60(4):357-361. PubMed ID: 28791267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
    Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
    J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients.
    Bean SM; Chhieng DC; Roberson J; Raper JL; Broker TR; Hoesley CJ; Eltoum IA; Jin G
    J Low Genit Tract Dis; 2010 Apr; 14(2):90-6. PubMed ID: 20354415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
    Duby JM; DiFurio MJ
    Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.
    Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LA; Myers O; Cuzick J; Wentzensen N; Kinney W; Castle PE; Wheeler CM;
    Obstet Gynecol; 2016 Dec; 128(6):1248-1257. PubMed ID: 27824767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.
    Wright TC; Stoler MH; Parvu V; Yanson K; Cooper C; Andrews J
    Gynecol Oncol; 2019 Aug; 154(2):360-367. PubMed ID: 31160073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated Positive Cervical HPV Testing and Absent or Minor Cytology Abnormality at Pap Smear. What is the Next Step?
    Caeiro V; Nunes S; Esteves B; Moutinho-Fonseca J
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1907-1912. PubMed ID: 34181350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
    Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S43-9. PubMed ID: 23519304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
    J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
    Fletcher AH; Wilkinson EJ; Knapik JA
    J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.
    Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S64-8. PubMed ID: 23519307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data.
    Aoki ES; Saika K; Kiguchi K; Morisada T; Aoki D
    J Gynecol Oncol; 2023 Mar; 34(2):e14. PubMed ID: 36424706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment to guide cervical screening strategies in a large Chinese population.
    Zhao FH; Hu SY; Zhang Q; Zhang X; Pan QJ; Zhang WH; Gage JC; Wentzensen N; Castle PE; Qiao YL; Katki HA; Schiffman M
    Int J Cancer; 2016 Jun; 138(11):2639-47. PubMed ID: 26800481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.
    Robbins HA; Strickler HD; Massad LS; Pierce CB; Darragh TM; Minkoff H; Keller MJ; Fischl M; Palefsky J; Flowers L; Rahangdale L; Milam J; Shrestha S; Colie C; DʼSouza G
    AIDS; 2017 Apr; 31(7):1035-1044. PubMed ID: 28323758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.